Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Vidotto, Alessandraa | Henrique, Tiagoa | Raposo, Luiz Sérgiob | Maniglia, José Victorb | Tajara, Eloiza H.a; c; *
Affiliations: [a] Departamento de Biologia Molécular, Faculdade de Medicina, São José do Rio Preto, Sáo Paulo, Brazil | [b] Departamento de Otorrinolaringologia, Faculdade de Medicina, São José do Rio Preto, São Paulo, Brazil | [c] Departamento de Genética e Biologia Evolutiva, Instituto de Biociências da Universidade de São Paulo, São Paulo, Brazil
Correspondence: [*] Corresponding author: Eloiza Helena Tajara, PhD, Department of Molecular Biology, School of Medicine/FAMERP, Av. Brig. Faria Lima 5416, São José do Rio Preto, CEP 15090-000, SP, Brazil. Tel.: +55 17 3201 5737; Fax: +55 17 3234 6407; E-mail: tajara@famerp.br.
Abstract: Several body fluids have been evaluated as new sources for cancer biomarker discovery. In this context, salivary and serum proteomics seem promising diagnostic and predictive tools for head and neck diseases. In the present study, we performed a proteomic analysis of saliva and serum from patients presenting head and neck squamous cell carcinoma (HNSCC) and compared the results before and after therapy. In saliva of cancer patients, we observed an altered protein profile, including over-expression of PLUNC and zinc-alpha-2-glycoprotein. Both proteins may contribute to control tumor growth and, therefore, represent targets for new analysis. We also detected serotransferrin and a modified transthyretin form with altered levels in serum from patients. Comparing preoperative and postreatment samples, the results showed that the protein profile after treatment reverted to a pattern closer to those observed for controls. These results add information on the role of secreted proteins in the cancer process and emphasize the potential of saliva and serum analysis for diagnosis and monitoring of HNSCC.
Keywords: Head and neck carcinoma, saliva, serum, proteomics, radiotherapy
DOI: 10.3233/CBM-2011-0205
Journal: Cancer Biomarkers, vol. 8, no. 2, pp. 95-107, 2011
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl